Varda Space Industries
Will Bruey, a former SpaceX engineer, and Delian Asparouhov of Founders Fund started Varda in January 2021. Varda makes small-molecule drug crystals in microgravity, where the process is harder on Earth, and returns them by capsule. Its first capsule, W-1, came down in Utah on February 21, 2024, under an FAA reentry license, carrying crystals of the antiretroviral drug ritonavir. W-5 returned in January 2026. W-6 landed on May 19, 2026, at the Koonibba Test Range in South Australia, carrying NASA and other U.S. government payloads and testing thermal protection.
Free-flying capsules that process materials in orbit and return through a hypersonic reentry.
W-6 launchesMar 30, 2026 W-6 reenters in AustraliaMay 19, 2026 W-8 and W-9 launch togetherOct 1, 2026 Varda's seventh capsule launches on Bandwagon-5Oct 20, 2026 Next capsule lands in AustraliaDec 2026 Next capsule lands in Australia · Dec 2026Will Bruey: Bruey talks with SpaceNews at AIAA ASCEND about connecting medicine with low Earth orbit and Varda's recent capsule re-entry over Australia.
Listen →Delian Asparouhov: He talks about his path from a Thiel Fellowship to building deep tech companies and his interest in technology and national security.
Listen →Will Bruey: Varda's cofounders discuss the company's origin, drug development in low gravity and the W-1 mission.
Listen →Delian Asparouhov: He and Will Bruey describe Varda's origin, its business case for in-space manufacturing and the W-1 mission.
Listen →Delian Asparouhov: He explains how Varda plans to manufacture in space and how the business works at current launch costs.
Listen →Starfall was one of 32 payloads on the Bandwagon-5 rideshare, launched October 20, alongside Varda's seventh W-Series capsule. The disk-shaped capsule can bring about 1,000 kg back to Earth.
Read →With W-8 and W-9 in orbit since October 1, Varda says another vehicle will launch within days, and it plans seven more flights next year.
Read →W-8 and W-9 rode Transporter-18 to orbit and will be run together from Varda's expanded mission operations center in El Segundo. The company has brought six capsules home since 2024.
Read →Varda Space Industries closed a $251 million Series D led by Lux Capital and Natural Capital, with Founders Fund, Khosla Ventures and General Catalyst among the other investors. The El Segundo company has now raised $598 million and says its first product made in space for use on Earth will be a pharmaceutical.
Read →